|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,500,000 |
Market
Cap: |
2.02(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$38.65 - $65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
32,136 |
396,652 |
637,244 |
1,063,187 |
Total Sell Value |
$1,498,005 |
$22,240,305 |
$34,650,077 |
$50,026,056 |
Total People Sold |
3 |
6 |
9 |
11 |
Total Sell Transactions |
5 |
14 |
31 |
71 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2020-03-17 |
4 |
D |
$14.50 |
$12,456 |
D/D |
(859) |
49,168 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2020-03-17 |
4 |
D |
$14.50 |
$14,384 |
D/D |
(992) |
80,891 |
|
- |
|
Shandell Jason B. |
President and General Counsel |
|
2020-03-17 |
4 |
D |
$14.50 |
$134,836 |
D/D |
(9,299) |
179,276 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2020-03-17 |
4 |
D |
$14.50 |
$49,793 |
D/D |
(3,434) |
104,038 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
68,303 |
1,449,961 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
D |
$13.03 |
$101,256 |
I/I |
(7,771) |
1,381,658 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
152,724 |
2,246,988 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
D |
$13.03 |
$337,125 |
D/D |
(25,873) |
2,094,264 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
18,726 |
50,027 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2020-03-16 |
4 |
D |
$13.03 |
$10,554 |
D/D |
(810) |
31,301 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
26,400 |
81,883 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2020-03-16 |
4 |
D |
$13.03 |
$13,291 |
D/D |
(1,020) |
55,483 |
|
- |
|
Shandell Jason B. |
President and General Counsel |
|
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
64,466 |
188,575 |
|
- |
|
Shandell Jason B. |
President and General Counsel |
|
2020-03-16 |
4 |
D |
$13.03 |
$102,846 |
D/D |
(7,893) |
124,109 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
40,291 |
107,472 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2020-03-16 |
4 |
D |
$13.03 |
$37,982 |
D/D |
(2,915) |
67,181 |
|
- |
|
Shandell Jason B. |
President and General Counsel |
|
2020-03-15 |
4 |
D |
$14.19 |
$97,854 |
D/D |
(6,896) |
132,002 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2020-03-15 |
4 |
D |
$14.19 |
$23,456 |
D/D |
(1,653) |
56,503 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2020-03-15 |
4 |
D |
$14.19 |
$22,122 |
D/D |
(1,559) |
32,111 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2020-03-15 |
4 |
D |
$14.19 |
$136,125 |
I/I |
(9,593) |
1,389,429 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2020-03-15 |
4 |
D |
$14.19 |
$385,670 |
D/D |
(27,179) |
2,120,137 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2020-03-15 |
4 |
D |
$14.19 |
$59,286 |
D/D |
(4,178) |
70,096 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2020-03-13 |
4 |
AS |
$13.66 |
$65,539 |
D/D |
(4,701) |
74,274 |
|
44% |
|
Petersen Floyd F. |
Director |
|
2020-03-02 |
4 |
AS |
$15.56 |
$7,782 |
D/D |
(500) |
72,642 |
|
28% |
|
Shandell Jason B. |
President and General Counsel |
|
2020-02-07 |
4 |
AS |
$19.88 |
$136,260 |
D/D |
(6,853) |
138,898 |
|
2% |
|
955 Records found
|
|
Page 16 of 39 |
|
|